Citigroup Inc. Stock
€53.70
Your prediction
Citigroup Inc. Stock
Pros and Cons of Citigroup Inc. in the next few years
Pros
Cons
Performance of Citigroup Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Citigroup Inc. | -0.460% | 2.762% | 5.992% | 29.797% | 15.972% | -12.970% | -7.143% |
Bank of America Corp. | 0.060% | 0.729% | 4.741% | 27.290% | 8.089% | 1.361% | 26.104% |
Citizens Financial | 0.690% | -1.913% | 4.377% | 5.342% | 1.318% | -19.053% | -0.550% |
Regions Financial Corp | 0.490% | -1.917% | 2.975% | -0.254% | 1.495% | -2.459% | 25.658% |
Comments
News
3 Stocks About to Boom on Unusual Call Option Volume
Most investors focus on the volume profile of the stocks they analyze, forgetting that there is another primary market that can act as a leading indicator. Options often give you a glimpse of the
1 Wall Street Analyst Raises Editas Medicine's Price Target by 45%. Here's Why She's Right.
With Citigroup analyst Samantha Semenkow calling on Feb. 29 for shares of Editas Medicine (NASDAQ: EDIT) to rise from their current price near $10 to reach $16 -- an increase of 45% over her prior
Snowflake Stock Has 35% Upside, According to 1 Wall Street Analyst
Snowflake (NYSE: SNOW) recently reported results for the fourth quarter and full year of fiscal 2024, where quarterly revenue and adjusted earnings were above Wall Street's expectations. However